Neurotensin (8-13) acetate salt

Suppliers

Names

[ CAS No. ]:
60482-95-3

[ Name ]:
Neurotensin (8-13) acetate salt

[Synonym ]:
Neurotensin(8-13)

Chemical & Physical Properties

[ Density]:
1.4 g/cm3

[ Molecular Formula ]:
C38H64N12O8

[ Molecular Weight ]:
816.99000

[ Exact Mass ]:
816.49700

[ PSA ]:
344.06000

[ LogP ]:
3.47920

[ Index of Refraction ]:
1.642

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier.

Neuropharmacology 48(3) , 417-25, (2005)

A set of neurotensin[8-13] (NT[8-13]) analogues (KK1-19) has been evaluated in various pre-clinical assays relevant for further development of these compounds as potential antipsychotics. Initial scre...

The neurotensin fragment AcNT(8-13) inhibits lowering of interstitial fluid pressure in rat trachea.

Am. J. Physiol. Heart Circ. Physiol. 283(3) , H933-40, (2002)

Injury to soft tissue results in the lowering of interstitial fluid pressure (P(if)), plasma protein extravasation, and increased total tissue volume. In this study, the effects of N-acetyl neurotensi...

Radiolabeling of multimeric neurotensin(8-13) analogs with the short-lived positron emitter fluorine-18.

Appl. Radiat. Isot. 65(7) , 818-26, (2007)

Three methods for (18)F-labeling of dimeric and tetrameric neurotensin(8-13) derivatives were evaluated with respect to the labeling yield and the required peptide amounts. Labeling using N-succinimid...


More Articles


Related Compounds

  • Neurotensin acetate salt
  • (D-Trp11)-Neurotensin acetate salt
  • (Dab9)-Neurotensin (8-13) trifluoroacetate salt
  • Acetyl-Neurotensin (8-13)
  • [Lys8, Lys9]-Neurotensin (8-13)
  • (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog)
  • N-(1-isobutyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-2-methylpropane-1-sulfonamide
  • N-(1-isobutyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)naphthalene-1-sulfonamide
  • N,N-diethyl-4-[(3-nitrophenyl)(1-piperazinyl)methyl]benzamide
  • N,N-Dimethyl-2-[[3-[4-(3-methyl-4-pyridinyl)-1-piperazinyl]propyl]amino]-3-pyridinecarboxamide
  • N1-((1-cyclopentylpiperidin-4-yl)methyl)-N2-(5-methylisoxazol-3-yl)oxalamide
  • (2-Amino-4-(trifluoromethyl)thiazol-5-yl)(phenyl)methanone
  • 2-((8-Methoxy-2-methylquinolin-4-yl)oxy)acetic acid
  • 1-(6-Bromo-5-Ethoxypyridin-3-Yl)-1,4-Diazepane
  • N1-(2-(cyclohex-1-en-1-yl)ethyl)-N2-((1-cyclopentylpiperidin-4-yl)methyl)oxalamide
  • 1-Chloro-3-[(2-hydroxyethyl)(phenylmethyl)amino]-2-propanol
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.